Internal Medicine, Endocrinology, Diabetes, & Metabolism · Manati, PR
NPI
1225427651
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
Mmc Professional Plaza, Urb Atenas Calle Hernandez Carrion
Manati, PR, 00674
Phone (787) 621-4828
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,186
78 services
Medicare patients, 2024
36
Average age 72
Drug cost, 2024
$4.0M
11,303 prescriptions
Company payments, 2025
$509
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naomi Collazo Gutierrez was code 99213 (office e&m - established), 56 times for 33 patients. In total Naomi Collazo Gutierrez billed 78 services in 8 codes, and Medicare paid $4,186.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 56 | 33 | $58.17 | $3,257 |
By year: 2022 $5,086 for 86 services; 2023 $5,104 for 82 services; 2024 $4,186 for 78 services.
Medicare prescription drug claims, 2024
In 2024, the drug Naomi Collazo Gutierrez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,904 prescriptions and refills. In total Naomi Collazo Gutierrez wrote 11,303 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,904 | 4,403 | 574 | $191K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 687 | 891 | 148 | $537K |
| Metformin Hcl Generic | 655 | 1,441 | 228 | $4,471 |
| Glipizide Generic | 558 | 1,111 | 167 | $8,330 |
| Farxiga Dapagliflozin Propanediol | 509 | 706 | 124 | $412K |
| Trulicity Dulaglutide | 457 | 466 | 69 | $462K |
| Ozempic Semaglutide | 445 | 453 | 80 | $438K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 406 | 483 | 79 | $41K |
| Jardiance Empagliflozin | 400 | 572 | 101 | $350K |
| Rosuvastatin Calcium Generic | 362 | 806 | 127 | $4,351 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 331 | 394 | 79 | $29K |
| Jentadueto Xr Linagliptin/Metformin Hcl | 305 | 416 | 60 | $215K |
| Humalog Insulin Lispro | 296 | 339 | 54 | $46K |
| Mounjaro Tirzepatide | 255 | 257 | 38 | $274K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 235 | 297 | 48 | $199K |
Brand drugs: 7,558 claims; generic drugs: 3,266 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naomi Collazo Gutierrez $509 ($509 in general payments such as food, travel and fees) from 7 companies. The largest payer was Beta Bionics, Inc. with $116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.